{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:16:58Z","timestamp":1781299018752,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer (CC) is one of the most common gynaecologic malignancies. The prognosis of stage IIIC1p cervical cancer patients treated by surgery is heterogeneous. Therefore, the aim of this study was to analyse the factors influencing the prognosis in such patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From January 2012 to December 2017, 102 patients with cervical cancer who underwent surgical treatment in the Department of Gynaecology and Tumours, Changzhou Maternal and Child Health Hospital, and had pelvic lymph node metastasis confirmed by pathology were analysed retrospectively. All patients underwent radical hysterectomy with\/without oophorectomy with pelvic lymphadenectomy with\/without para-aortic lymphadenectomy. Clinical data was collected including age, surgical method, ovarian status, intraoperative blood loss, perioperative complications, tumour size, pathological type, depth of stromal invasion (DSI), whether the lymphatic vascular space was infiltrated, number of pelvic lymph node metastases, location of pelvic lymph node metastases, total number of lymph nodes resected, lymph node ratio (LNR), nature of vaginal margin, whether parametrium was involved, postoperative adjuvant therapy, preoperative neutrophil\u2013lymphocyte ratio (NLR) and prognostic information of patients. Survival curves for overall survival (OS) and disease-free survival (DFS) were plotted using the Kaplan\u2013Meier method, and the difference between the survival curves was tested using the log-rank test. Univariate and multivariate COX regression models were used to assess the factors associated with overall survival and disease-free survival in patients with stage IIIC1p cervical cancer. Nomogram plots were constructed to predict OS and DFS, and the predictive accuracy of the nomograms was measured by Harrell\u2019s C-index and calibration curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 102 patients with stage IIIC1p cervical cancer were included in the study, and the median follow-up time was 63\u00a0months (range from 6 to 130\u00a0months). The 5-year OS was 64.7%, and the 5-year DFS was 62.7%. Multivariate analysis showed that no postoperative adjuvant therapy, LNR\u2009&gt;\u20090.3 and NLR\u2009&gt;\u20093.8 were independent risk factors for OS and DFS in patients with stage IIIC1p cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with stage IIIC1p cervical cancer have a poor prognosis. Lower OS and DFS were associated with no postoperative adjuvant therapy, LNR\u2009&gt;\u20090.3 and NLR\u2009&gt;\u20093.8.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-023-03076-9","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T04:02:22Z","timestamp":1687320142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiang","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"issue":"4","key":"3076_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","volume":"28","author":"D Cibula","year":"2018","unstructured":"Cibula D, P\u00f6tter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int J Gynecol Cancer. 2018;28(4):641\u201355.","journal-title":"Int J Gynecol Cancer"},{"key":"3076_CR2","volume-title":"NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version I.2018) National Comprehensive Cancer Network","author":"National Comprehensive Cancer Network","year":"2017","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version I.2018) National Comprehensive Cancer Network. PA, USA: Plymouth Meeting; 2017."},{"issue":"20","key":"3076_CR3","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.3390\/ijerph192013176","volume":"19","author":"B Pecorino","year":"2022","unstructured":"Pecorino B, D\u2019Agate MG, Scibilia G, Scollo P, Giannini A, Di Donna MC, et al. Evaluation of surgical outcomes of abdominal radical hysterectomy and total laparoscopic radical hysterectomy for cervical cancer: a retrospective analysis of data collected before the LACC trial. Int J Environ Res Public Health. 2022;19(20):13176.","journal-title":"Int J Environ Res Public Health"},{"issue":"20","key":"3076_CR4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","volume":"379","author":"PT Ramirez","year":"2018","unstructured":"Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895\u2013904.","journal-title":"N Engl J Med"},{"issue":"18","key":"3076_CR5","doi-asserted-by":"publisher","first-page":"11641","DOI":"10.3390\/ijerph191811641","volume":"19","author":"G Bogani","year":"2022","unstructured":"Bogani G, Di Donato V, Scambia G, Raspagliesi F, Chiantera V, Sozzi G, et al. Radical hysterectomy for early stage cervical cancer. Int J Environ Res Public Health. 2022;19(18):11641.","journal-title":"Int J Environ Res Public Health"},{"key":"3076_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952347","volume":"12","author":"M Wang","year":"2022","unstructured":"Wang M, Ma M, Yang L, Liang C. Development and validation of a nomogram for predicting pelvic lymph node metastasis and prognosis in patients with cervical cancer. Front Oncol. 2022;12: 952347.","journal-title":"Front Oncol"},{"issue":"Suppl 2","key":"3076_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):22\u201336.","journal-title":"Int J Gynaecol Obstet"},{"key":"3076_CR8","unstructured":"Abu-rustum NR, Yashar CM, Bradley K, et al. NCCN Clinical Practice Guidelines in Oncology, Cervical Cancer. Version 1. 2022. https:\/\/www.nccnchina.org.cn\/guide\/detail\/226."},{"issue":"7","key":"3076_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/jog.14305","volume":"46","author":"JM Ryu","year":"2020","unstructured":"Ryu JM, Choi YS, Bae JY. Prognostic factors in women with cervical cancer stage IIIC1r treated with concurrent chemoradiotherapy. J Obstet Gynaecol Res. 2020;46(7):1165\u201372.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"3076_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ijgc-2021-003014","volume":"32","author":"A Fernandes","year":"2022","unstructured":"Fernandes A, Viveros-Carre\u00f1o D, Hoegl J, \u00c1vila M, Pareja R. Human papillomavirus-independent cervical cancer. Int J Gynecol Cancer. 2022;32(1):1\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"3076_CR11","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.2147\/IJGM.S372154","volume":"15","author":"J Xu","year":"2022","unstructured":"Xu J, Ma YL, Mei HB, Wang Q. Diagnostic value of multimodal magnetic resonance imaging in discriminating between metastatic and non-metastatic pelvic lymph nodes in cervical cancer. Int J Gen Med. 2022;15:6279\u201388.","journal-title":"Int J Gen Med"},{"issue":"4","key":"3076_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jso.21199","volume":"99","author":"LT Gien","year":"2009","unstructured":"Gien LT, Covens A. Lymph node assessment in cervical cancer: prognostic and therapeutic implications. J Surg Oncol. 2009;99(4):242\u20137.","journal-title":"J Surg Oncol"},{"issue":"4","key":"3076_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7888\/juoeh.42.317","volume":"42","author":"A Tohyama","year":"2020","unstructured":"Tohyama A, Murakami M, Yoshino K. Strategies for the treatment of cervical cancer with bulky pelvic lymph nodes: an overview of the current evidence. J UOEH. 2020;42(4):317\u201325.","journal-title":"J UOEH"},{"issue":"3","key":"3076_CR14","first-page":"498","volume":"15","author":"P Suprasert","year":"2005","unstructured":"Suprasert P, Srisomboon J, Charoenkwan K, Siriaungul S, Khunamornpong S, Siriaree S, et al. Outcomes of abandoned radical hysterectomy in patients with stages IB-IIA cervical cancer found to have positive nodes during the operation. Int J Gynecol Cancer. 2005;15(3):498\u2013502.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"3076_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/IGC.0000000000000974","volume":"27","author":"M Derks","year":"2017","unstructured":"Derks M, Groenman FA, van Lonkhuijzen LRCW, Schut PC, Westerveld H, van der Velden J, et al. Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity. Int J Gynecol Cancer. 2017;27(5):1015\u201320.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"3076_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/cncr.26317","volume":"118","author":"G Ferrandina","year":"2012","unstructured":"Ferrandina G, Petrillo M, Restaino G, Rufini V, Macchia G, Carbone A, et al. Can radicality of surgery be safely modulated on the basis of MRI and PET\/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? Cancer. 2012;118(2):392\u2013403.","journal-title":"Cancer"},{"issue":"3","key":"3076_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/jamaoncol.2020.7168","volume":"7","author":"H Huang","year":"2021","unstructured":"Huang H, Feng YL, Wan T, Zhang YN, Cao XP, Huang YW, et al. Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer: The STARS Phase 3 Randomized Clinical Trial. JAMA Oncol. 2021;7(3):361\u20139.","journal-title":"JAMA Oncol"},{"issue":"1","key":"3076_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/AOG.0000000000003311","volume":"134","author":"JD Wright","year":"2019","unstructured":"Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, et al. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines. Obstet Gynecol. 2019;134(1):49\u201357.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"3076_CR19","doi-asserted-by":"publisher","first-page":"300060519889741","DOI":"10.1177\/0300060519889741","volume":"48","author":"D Li","year":"2020","unstructured":"Li D, Xu X, Yan D, Yuan S, Ni J, Lou H. Prognostic factors affecting survival and recurrence in patients with early cervical squamous cell cancer following radical hysterectomy. J Int Med Res. 2020;48(4):300060519889741.","journal-title":"J Int Med Res"},{"key":"3076_CR20","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.2147\/CMAR.S253522","volume":"12","author":"A Li","year":"2020","unstructured":"Li A, Wang L, Jiang Q, Wu W, Huang B, Zhu H. Risk Stratification Based on Metastatic Pelvic Lymph Node Status in Stage IIIC1p Cervical Cancer. Cancer Manag Res. 2020;12:6431\u20139.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3076_CR21","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e1","volume":"31","author":"K Aslan","year":"2020","unstructured":"Aslan K, Meydanli MM, Oz M, Tohma YA, Haberal A, Ayhan A. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy. J Gynecol Oncol. 2020;31(1): e1.","journal-title":"J Gynecol Oncol"},{"key":"3076_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/CMAR.S141335","volume":"9","author":"J Zhou","year":"2017","unstructured":"Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Wang Y, et al. The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Cancer Manag Res. 2017;9:315\u201322.","journal-title":"Cancer Manag Res"},{"key":"3076_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11596-018-1915-0","volume":"38","author":"BX Huang","year":"2018","unstructured":"Huang BX, Fang F. Progress in the study of lymph node metastasis in early-stage cervical cancer. Curr Med Sci. 2018;38:567\u201374.","journal-title":"Curr Med Sci"},{"issue":"5","key":"3076_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/aogs.14316","volume":"101","author":"EP Olthof","year":"2022","unstructured":"Olthof EP, Mom CH, Snijders MLH, Wenzel HHB, van der Velden J, van der Aa MA. The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer. Acta Obstet Gynecol Scand. 2022;101(5):550\u20137.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"3076_CR25","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.21037\/tcr-20-1355","volume":"9","author":"C Jin","year":"2020","unstructured":"Jin C, Li J, Zou C, Qiao X, Ma P, Hu D, et al. Lymph node ratio predicts prognosis in patients with surgically resected invasive pancreatic cystic neoplasms. Transl Cancer Res. 2020;9(10):5843\u201356.","journal-title":"Transl Cancer Res"},{"key":"3076_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.amsu.2020.04.002","volume":"54","author":"C Supsamutchai","year":"2020","unstructured":"Supsamutchai C, Wilasrusmee C, Jirasiritham J, Rakchob T, Phosuwan S, Chatmongkonwat T, et al. Recurrence outcome of lymph node ratio in gastric cancer after underwent curative resection: A retrospective cohort study. Ann Med Surg (Lond). 2020;54:57\u201361.","journal-title":"Ann Med Surg (Lond)"},{"issue":"4","key":"3076_CR27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5152\/ejbh.2020.5809","volume":"16","author":"A Sakin","year":"2020","unstructured":"Sakin A, Aldemir MN. Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer. Eur J Breast Health. 2020;16(4):270\u20135.","journal-title":"Eur J Breast Health"},{"issue":"3","key":"3076_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3349\/ymj.2021.62.3.231","volume":"62","author":"SI Kim","year":"2021","unstructured":"Kim SI, Kim TH, Lee M, Kim HS, Chung HH, Lee TS, et al. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy. Yonsei Med J. 2021;62(3):231\u20139.","journal-title":"Yonsei Med J"},{"issue":"9","key":"3076_CR29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/ijgc-2019-000669","volume":"29","author":"G Bogani","year":"2019","unstructured":"Bogani G, Vinti D, Murgia F, Chiappa V, Maggiore U Leone Roberti, Martinelli F, et al. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer. Int J Gynecol Cancer. 2019;29(9):1355\u201360.","journal-title":"Int J Gynecol Cancer."},{"key":"3076_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011711","volume":"97","author":"JH Joo","year":"2018","unstructured":"Joo JH, Kim YS, Nam JH. Prognostic significance of lymph node ratio in node-positive cervical cancer patients. Medicine (Baltimore). 2018;97: e11711.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"3076_CR31","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.7150\/thno.54023","volume":"11","author":"R Mastrantonio","year":"2021","unstructured":"Mastrantonio R, You H, Tamagnone L. Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer. Theranostics. 2021;11(7):3262\u201377.","journal-title":"Theranostics"},{"issue":"28","key":"3076_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026335","volume":"100","author":"L Xu","year":"2021","unstructured":"Xu L, Song J. Elevated neutrophil-lymphocyte ratio can be a biomarker for predicting the development of cervical intraepithelial neoplasia. Medicine (Baltimore). 2021;100(28): e26335.","journal-title":"Medicine (Baltimore)"},{"key":"3076_CR33","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7132","volume":"7","author":"D Wang","year":"2019","unstructured":"Wang D, Bai N, Hu X, OuYang XW, Yao L, Tao Y, et al. Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC. PeerJ. 2019;7: e7132.","journal-title":"PeerJ"},{"key":"3076_CR34","doi-asserted-by":"crossref","unstructured":"Liu C, Li X. Stage-dependent changes in albumin, NLR, PLR, and AFR are correlated with shorter survival in patients with gastric cancer. Clin Lab. 2019;65(9):1623-33.","DOI":"10.7754\/Clin.Lab.2019.190132"},{"issue":"9","key":"3076_CR35","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1002\/cam4.2281","volume":"8","author":"W Guo","year":"2019","unstructured":"Guo W, Lu X, Liu Q, Zhang T, Li P, Qiao W, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: an updated meta-analysis of 17079 individuals. Cancer Med. 2019;8(9):4135\u201348.","journal-title":"Cancer Med"},{"key":"3076_CR36","doi-asserted-by":"publisher","first-page":"4659048","DOI":"10.1155\/2019\/4659048","volume":"2019","author":"Y Chen","year":"2019","unstructured":"Chen Y, Jin M, Shao Y, Xu G. Prognostic value of the systemic inflammation response index in patients with adenocarcinoma of the oesophagogastric junction: a propensity score-matched analysis. Dis Markers. 2019;2019:4659048.","journal-title":"Dis Markers"},{"key":"3076_CR37","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fonc.2020.00766","volume":"10","author":"B Chao","year":"2020","unstructured":"Chao B, Ju X, Zhang L, Xu X, Zhao Y. A novel prognostic marker systemic inflammation response index (SIRI) for operable cervical cancer patients. Front Oncol. 2020;10:766.","journal-title":"Front Oncol"},{"issue":"3","key":"3076_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ygyno.2022.07.022","volume":"166","author":"G Bogani","year":"2022","unstructured":"Bogani G, Donato VD, Scambia G, Landoni F, Ghezzi F, Muzii L, et al. Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer. Gynecol Oncol. 2022;166(3):561\u20136.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3076_CR39","doi-asserted-by":"publisher","first-page":"249.e1","DOI":"10.1016\/j.ajog.2019.09.036","volume":"222","author":"A Obermair","year":"2020","unstructured":"Obermair A, Asher R, Pareja R, Frumovitz M, Lopez A, Moretti-Marques R, et al. Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial. Am J Obstet Gynecol. 2020;222(3):249.e1-249.e10.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"3076_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1136\/ijgc-2020-001381","volume":"30","author":"G Bogani","year":"2020","unstructured":"Bogani G, Ghezzi F, Chiva L, Gisone B, Pinelli C, Dell\u2019Acqua A, et al. Patterns of recurrence after laparoscopic versus open abdominal radical hysterectomy in patients with cervical cancer: a propensity-matched analysis. Int J Gynecol Cancer. 2020;30(7):987\u201392.","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"3076_CR41","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/ijgc-2020-001506","volume":"30","author":"L Chiva","year":"2020","unstructured":"Chiva L, Zanagnolo V, Querleu D, Martin-Calvo N, Ar\u00e9valo-Serrano J, C\u0103p\u00eelna ME, et al. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. Int J Gynecol Cancer. 2020;30(9):1269\u201377.","journal-title":"Int J Gynecol Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03076-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03076-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03076-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T04:02:57Z","timestamp":1687320177000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03076-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3076"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03076-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2730180\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"24 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). This study was approved by the Ethics Committee of Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University (No.2022028). Written informed consent was obtained from all participants. We confirmed that all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}